Latest News
Latest News
Semaglutide prescribing surged in the past year
General and family practice providers were the most frequent semaglutide providers (30%), followed by internists (15%).
Latest News
84-year-old MD contests employer’s mandatory cognitive tests for older docs
According to the lawsuit, the hospital illegally required neuropsychological and eye examinations of physicians aged 70 or older who sought to...
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Conference Coverage
Drug-eluting resorbable scaffold beats angioplasty for infrapopliteal artery disease
“If this technology is approved by the FDA, it will provide a new option for our patients with very difficult-to-treat disease, which will provide...
From the Journals
Another study ties statins to T2D: Should practice change?
“When using rosuvastatin over atorvastatin, we ... emphasize the importance of meticulous monitoring and appropriate lifestyle interventions to...
Conference Coverage
No benefit of colchicine after stroke, TIA: CHANCE-3
“We require randomized trials with longer follow-up prior to abandoning this potential treatment.”
From the Journals
Portfolio diet tied to lower risk for CVD, stroke
The diet aligns with American Heart Association guidelines promoting consumption of whole grains, fruits and vegetables, plant-based proteins,...
Conference Coverage
Low-risk TAVR studies: Divergent long-term results
“Cardiovascular mortality occurred at a rate of about 1% per year with both therapies, strokes at the rate of 1% per year with both therapies, and...
Conference Coverage
Trilogy TAVR safe, effective in aortic regurgitation
One-year mortality rate of 7.8% reported.
From the Journals
Chinese medicine improves outcomes in STEMI patients
Unlike most traditional Chinese medicine research, the design of this study incorporated all key elements of randomized clinical trials, including...
Latest News
Orthostatic hypotension no deterrent to hypertension treatment
Intensive antihypertensive treatment provides the same benefit for cardiovascular disease and all-cause mortality regardless of orthostatic or...